The manometry system market is gaining traction across the global healthcare landscape, driven by increasing awareness of gastrointestinal and esophageal disorders. Manometry systems are medical ...

The global Headspace Gas Analyzers Market is estimated to be valued at USD 655.7 million in 2025 and is projected to reach USD 1,120.1 million by 2035, registering a compound annual growth rate (CAGR) ...

The pelvic floor diagnostics market is gaining momentum as awareness grows around pelvic floor disorders and the need for early diagnosis. These conditions, which include urinary incontinence, pelvic ...

The global high flow oxygen therapy devices market is anticipated to witness moderate growth, rising from USD 1.3 billion in 2025 to USD 1.6 billion by 2035 at a CAGR of 2.1% over the forecast period.

The active humidifier devices market has emerged as a critical component in various industries, especially in healthcare settings. These devices are designed to maintain optimal humidity levels in ...

The market has benefited from increased public awareness about health issues, urbanization and the spread of e-commerce sites on the internet. All of these factors have given consumers more choice in ...

The pelvic floor stimulators market will hit USD 166.1 Million come 2025. By 2035, it is set to grow more, reaching USD 393.4 Million. The rise will show a CAGR of 9% during the time frame. Demand for ...

Additionally, the market is advancing as novel, rapid, and precise testing tools. The Americas COVID-19 testing market was valued at around USD 5.8 Billion in 2025, backed by the continued need for ...

The insulin pens market is witnessing significant growth due to the increasing prevalence of diabetes worldwide and the rising preference for advanced, user-friendly insulin delivery systems. Insulin ...

The International Photodynamic Association (IPA) is pleased to announce that Dr. Stuart Bond, Consultant Antimicrobial Pharmacist and Director of Innovation at Mid Yorkshire Hospitals NHS Trust, has ...

LUND, SE / ACCESS Newswire / June 13, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immunotherapies, today announced that the U ...

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the ...